The New York Mets have reached a two-year agreement worth $20 million with free-agent pitcher Taijuan Walker. According to Joel Sherman of the New York Post, the deal includes a player option for a third year.

Walker gets $10M in 2021, $7M in 2022. 2023 player option that starts at $6M with escalators can get to $8.5M or $3M buyout on the player option. #Mets All of this is pending a physical.

— Joel Sherman (@Joelsherman1) February 19, 2021

Walker will provide depth to a Mets rotation that already includes former Cy Young winner Jacob deGrom, Carlos Carrasco, Marcus Stroman. Noah Syndergaard is also expected to rejoin the Mets rotation later this season after having Tommy John surgery last year.

Walker split time last year between the Mariners and Blue Jays. He finished 4-3 on the season with a 2.70 ERA in 53 1/3 innings. It was the most innings he’s pitched since 2017 when he recorded 157 1/3 innings and finished 9-9 with a 3.49 ERA. In 2018 and 2019, he combined for just 14 innings after a partial tear of the UCL in his right elbow required surgery. If he can stay healthy this season, he could be the most underrated signing this offseason.

Walker hasn’t always been on winning clubs, but he’s 35-34 with a 3.84 ERA and 1.25 WHIP over his eight-year career. He’ll be joining a Mets rotation that was 21st in league with 13 wins and 26th with a 5.37 ERA.

Head over to FanDuel Sportsbook, where you can find all your preseason MLB odds. The Mets currently have the second shortest odds to win the NL East at +145. They’re also +550 to win the pennant and +1000 to win the World Series.